Posts in Japanese pharmaceutical companies

Stefan speaking on stage at a pharmaceutical industry conference, in front of a large presentation screen about Daiichi Sankyo, antibody-drug conjugates, and new business opportunities in oncology.
by Stefan Sandström
August 10, 2026

Daiichi Sankyo ADC strategy: Where Your New Opportunities Lie

Daiichi Sankyo has built one of the pharmaceutical industry’s most productive antibody-drug conjugate platforms. Enhertu has […]
0
read more
A photorealistic illuminated billboard beside a wet city road at dusk, displaying: "Otsuka's new target is to hit ¥3.5 trillion by 2035."
by Stefan Sandström
August 4, 2026

New Ambitious Goals and Strategies for Otsuka: Where Your New Opportunities Are

Large pharmaceutical targets often look like abstract financial noise to external vendors. But Otsuka’s target to […]
0
read more